Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022

Detalles Bibliográficos
Autores principales: Surie, Diya, DeCuir, Jennifer, Zhu, Yuwei, Gaglani, Manjusha, Ginde, Adit A., Douin, David J., Talbot, H. Keipp, Casey, Jonathan D., Mohr, Nicholas M., Zepeski, Anne, McNeal, Tresa, Ghamande, Shekhar, Gibbs, Kevin W., Files, D. Clark, Hager, David N., Ali, Harith, Taghizadeh, Leyla, Gong, Michelle N., Mohamed, Amira, Johnson, Nicholas J., Steingrub, Jay S., Peltan, Ithan D., Brown, Samuel M., Martin, Emily T., Khan, Akram, Bender, William S., Duggal, Abhijit, Wilson, Jennifer G., Qadir, Nida, Chang, Steven Y., Mallow, Christopher, Kwon, Jennie H., Exline, Matthew C., Lauring, Adam S., Shapiro, Nathan I., Columbus, Cristie, Halasa, Natasha, Chappell, James D., Grijalva, Carlos G., Rice, Todd W., Stubblefield, William B., Baughman, Adrienne, Womack, Kelsey N., Rhoads, Jillian P., Hart, Kimberly W., Swan, Sydney A., Lewis, Nathaniel M., McMorrow, Meredith L., Self, Wesley H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812444/
https://www.ncbi.nlm.nih.gov/pubmed/36580424
http://dx.doi.org/10.15585/mmwr.mm715152e2

Ejemplares similares

Ejemplares similares